tetano
Editor, Senior Moderator
Int J Environ Res Public Health
. 2021 Dec 15;18(24):13201.
doi: 10.3390/ijerph182413201.
Severe COVID-19 Complicated by Cerebral Venous Thrombosis in a Newborn Successfully Treated with Remdesivir, Glucocorticoids, and Hyperimmune Plasma
Laura Cursi[SUP] 1 [/SUP], Francesca Ippolita Calo Carducci[SUP] 1 [/SUP], Sara Chiurchiu[SUP] 1 [/SUP], Lorenza Romani[SUP] 1 [/SUP], Francesca Stoppa[SUP] 2 [/SUP], Giulia Lucignani[SUP] 3 [/SUP], Cristina Russo[SUP] 4 [/SUP], Daniela Longo[SUP] 3 [/SUP], Carlo Federico Perno[SUP] 4 [/SUP], Corrado Cecchetti[SUP] 2 [/SUP], Mary Haywood Lombardi[SUP] 2 [/SUP], Patrizia D'Argenio[SUP] 1 [/SUP], Laura Lancella[SUP] 1 [/SUP], Stefania Bernardi[SUP] 1 [/SUP], Paolo Rossi[SUP] 1 [/SUP]
Affiliations
Abstract
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19) pandemic, affecting all age groups with a wide spectrum of clinical presentation ranging from asymptomatic to severe interstitial pneumonia, hyperinflammation, and death. Children and infants generally show a mild course of the disease, although infants have been observed to have a higher risk of hospitalization and severe outcomes. Here, we report the case of a preterm infant with a severe form of SARS-CoV-2 infection complicated by cerebral venous thrombosis successfully treated with steroids, hyperimmune plasma, and remdesivir.
Keywords: COVID-19; SARS-CoV-2; cerebral thrombosis; newborn; remdesivir.
. 2021 Dec 15;18(24):13201.
doi: 10.3390/ijerph182413201.
Severe COVID-19 Complicated by Cerebral Venous Thrombosis in a Newborn Successfully Treated with Remdesivir, Glucocorticoids, and Hyperimmune Plasma
Laura Cursi[SUP] 1 [/SUP], Francesca Ippolita Calo Carducci[SUP] 1 [/SUP], Sara Chiurchiu[SUP] 1 [/SUP], Lorenza Romani[SUP] 1 [/SUP], Francesca Stoppa[SUP] 2 [/SUP], Giulia Lucignani[SUP] 3 [/SUP], Cristina Russo[SUP] 4 [/SUP], Daniela Longo[SUP] 3 [/SUP], Carlo Federico Perno[SUP] 4 [/SUP], Corrado Cecchetti[SUP] 2 [/SUP], Mary Haywood Lombardi[SUP] 2 [/SUP], Patrizia D'Argenio[SUP] 1 [/SUP], Laura Lancella[SUP] 1 [/SUP], Stefania Bernardi[SUP] 1 [/SUP], Paolo Rossi[SUP] 1 [/SUP]
Affiliations
- PMID: 34948814
- DOI: 10.3390/ijerph182413201
Abstract
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19) pandemic, affecting all age groups with a wide spectrum of clinical presentation ranging from asymptomatic to severe interstitial pneumonia, hyperinflammation, and death. Children and infants generally show a mild course of the disease, although infants have been observed to have a higher risk of hospitalization and severe outcomes. Here, we report the case of a preterm infant with a severe form of SARS-CoV-2 infection complicated by cerebral venous thrombosis successfully treated with steroids, hyperimmune plasma, and remdesivir.
Keywords: COVID-19; SARS-CoV-2; cerebral thrombosis; newborn; remdesivir.